Anders Hedegaard

Anders Hedegaard is a highly accomplished executive with a strong background in Chemical Engineering and Biochemistry.

He holds a Master of Science degree from The Technical University of Denmark (DTU).

Additionally, Anders completed the Advanced Management Programme at INSEAD and the International Directors Programme at the same institution.

Anders Hedegaard has held several prominent positions in various organizations, showcasing his versatile skill set and leadership capabilities.

Currently, he serves as the Chief Executive Officer at Rodenstock Group, overseeing the strategic direction and operations of the company.

Previously, Anders was the Chairman Of The Board at ALK and a Board Member at Orphazyme A/S, demonstrating his experience in governance and boardroom dynamics.

His executive experience includes roles such as President & CEO at GN Hearing A/S, President & CEO at Bavarian Nordic A/S, and Executive Vice President at ALK-Abello A/S.

Anders has also served in leadership positions at Origio A/S, FOSS A/S, and Novo Nordisk A/S, where he honed his expertise in sales and marketing.

With his extensive experience across diverse industries, Anders Hedegaard brings a wealth of knowledge and a proven track record of success to any organization he is a part of.